Snapshots

Search

Search managers or tickers

RXRX Recursion Pharmaceuticals In

held by 1 manager in Q3 2022 Latest
Manager% of their portfolioHeldActivityValueShares
Stanley Druckenmiller Duquesne Family Office 0.85% 1.3 yr Add ×5.1 $15M 1,385,950